
SABSW
USDSAB Biotherapeutics Inc. Warrant
실시간 가격
가격 차트
핵심 지표
시장 지표
시가
$0.048
고가
$0.039
저가
$0.028
거래량
0.01M
기업 기본 정보
산업
생명공학
국가
United States
거래 통계
거래소
NCM
통화
USD
52주 범위
관련 뉴스
SAB BIO to Present Data at the International Society for Pediatric and Adolescent Diabetes Annual Conference Showcasing Progress in the Development of SAB-142
MIAMI, Nov. 04, 2025 (GLOBE NEWSWIRE) -- SAb Biotherapeutics, Inc. (NASDAQ:SABS), a clinical-stage biopharmaceutical company developing human anti-thymocyte immunoglobulin (hATG) for type 1 diabetes (T1D) and other
SAB BIO to Participate in Upcoming Investor Conferences
MIAMI, Nov. 04, 2025 (GLOBE NEWSWIRE) -- SAb Biotherapeutics, Inc. (Nasdaq: SABS), a clinical-stage biopharmaceutical company developing human anti-thymocyte immunoglobulin (hATG) for autoimmune diseases, including its
관련 주식
CASI
CASI Pharmaceuticals Inc. Ordinary Shares
JAMF
Jamf Holding Corp.
SCNI
Scinai Immunotherapeutics Ltd. American Depositary Shares
NQP
Nuveen Pennsylvania Quality Municipal Income Fund
ICUCW
SeaStar Medical Holding Corporation Warrant
최신 정보 받기
가격 알림 설정, AI 분석 업데이트 및 실시간 시장 뉴스 받기